OTCQX:MRVFF - Post by User
Comment by
need2stockupon Feb 29, 2012 7:16am
![](https://assets.stockhouse.com/kentico-cms/0338-00/images/Sprite.svg#id_Post_Views_Icon)
281 Views
Post# 19602781
RE: RE: What's up with Synera?
RE: RE: What's up with Synera? Mr. 99. That article was a 2009 article. That was 3 years ago. I guess a re-launch is long overdue because Endo didn't like the drug. We have bought 2 rejected drug products and we are hoping we can resell them again most likely to the same Doctors. Nuvo/Zars should of been smart and changed the names. The Doctors are going to say....oh that drug. I can't see this going very far. As well this November Pennsaid's market exclusivity is over and generic versions will be open to be sold if they have FDA approval. According to Nuvo's January presentation chart 2011 sales are no where near Voltaren and the Flector patch. It seems that Pennsaid Gel (Pennsaid 2%) will be the only one to work in the market. Wait a minute Voltaren is a Gel and is the top seller in the market. Second place again or third or what ever. The Car guys are going to acquire more drugs to meet end points to get raises in wages not in the stock price. Need2.